Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT554 | Organism | Candida glabrata | Candida glabrata | MIC | = | 30 | ug/ml | 14640511 |
NPT20 | Organism | Candida albicans | Candida albicans | MIC | = | 30 | ug/ml | 14640511 |
NPT20 | Organism | Candida albicans | Candida albicans | MIC | = | 100 | ug/ml | 20462236 |
NPT187 | Organism | Issatchenkia orientalis | Pichia kudriavzevii | MIC | = | 30 | ug/ml | 15711537 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC45906 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC288415 |
1.0 | High Similarity | NPC31313 |
1.0 | High Similarity | NPC149908 |
0.9868 | High Similarity | NPC93630 |
0.9737 | High Similarity | NPC81006 |
0.9221 | High Similarity | NPC90839 |
0.8667 | High Similarity | NPC127553 |
0.8667 | High Similarity | NPC255050 |
0.6795 | Remote Similarity | NPC112398 |
0.6774 | Remote Similarity | NPC168017 |
0.6703 | Remote Similarity | NPC124359 |
0.6632 | Remote Similarity | NPC178632 |
0.618 | Remote Similarity | NPC477002 |
0.6145 | Remote Similarity | NPC233034 |
0.6078 | Remote Similarity | NPC313821 |
0.6022 | Remote Similarity | NPC471420 |
0.593 | Remote Similarity | NPC126664 |
0.593 | Remote Similarity | NPC34291 |
0.5882 | Remote Similarity | NPC238646 |
0.5865 | Remote Similarity | NPC91036 |
0.5859 | Remote Similarity | NPC470284 |
0.5833 | Remote Similarity | NPC163134 |
0.5833 | Remote Similarity | NPC471419 |
0.5825 | Remote Similarity | NPC119225 |
0.5825 | Remote Similarity | NPC476261 |
0.5825 | Remote Similarity | NPC471635 |
0.5825 | Remote Similarity | NPC25033 |
0.5825 | Remote Similarity | NPC470382 |
0.581 | Remote Similarity | NPC220111 |
0.5806 | Remote Similarity | NPC150557 |
0.5794 | Remote Similarity | NPC314387 |
0.5769 | Remote Similarity | NPC243635 |
0.5769 | Remote Similarity | NPC151004 |
0.5769 | Remote Similarity | NPC228980 |
0.5758 | Remote Similarity | NPC470282 |
0.573 | Remote Similarity | NPC476696 |
0.573 | Remote Similarity | NPC476695 |
0.573 | Remote Similarity | NPC476694 |
0.5701 | Remote Similarity | NPC144714 |
0.5701 | Remote Similarity | NPC100810 |
0.5686 | Remote Similarity | NPC145707 |
0.5679 | Remote Similarity | NPC293551 |
0.5673 | Remote Similarity | NPC155985 |
0.5641 | Remote Similarity | NPC475887 |
0.5607 | Remote Similarity | NPC56298 |
0.5607 | Remote Similarity | NPC471628 |
0.56 | Remote Similarity | NPC52533 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC45906 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.6168 | Remote Similarity | NPD8140 | Approved |
0.6145 | Remote Similarity | NPD9440 | Discontinued |
0.6087 | Remote Similarity | NPD8347 | Approved |
0.6087 | Remote Similarity | NPD8345 | Approved |
0.6087 | Remote Similarity | NPD8346 | Approved |
0.6078 | Remote Similarity | NPD3190 | Approved |
0.6078 | Remote Similarity | NPD3189 | Approved |
0.6078 | Remote Similarity | NPD3191 | Approved |
0.6019 | Remote Similarity | NPD8307 | Discontinued |
0.593 | Remote Similarity | NPD9443 | Clinical (unspecified phase) |
0.5872 | Remote Similarity | NPD7646 | Clinical (unspecified phase) |
0.5844 | Remote Similarity | NPD7348 | Clinical (unspecified phase) |
0.5794 | Remote Similarity | NPD3183 | Approved |
0.5794 | Remote Similarity | NPD3184 | Approved |
0.5794 | Remote Similarity | NPD3182 | Approved |
0.5794 | Remote Similarity | NPD3185 | Approved |
0.5783 | Remote Similarity | NPD9022 | Phase 2 |
0.5783 | Remote Similarity | NPD9024 | Phase 2 |
0.5769 | Remote Similarity | NPD1821 | Approved |
0.5769 | Remote Similarity | NPD1822 | Approved |
0.5769 | Remote Similarity | NPD1823 | Approved |
0.573 | Remote Similarity | NPD7535 | Discontinued |
0.5729 | Remote Similarity | NPD883 | Phase 2 |
0.5729 | Remote Similarity | NPD882 | Phase 2 |
0.5714 | Remote Similarity | NPD8087 | Discontinued |
0.5699 | Remote Similarity | NPD8143 | Approved |
0.5699 | Remote Similarity | NPD8144 | Approved |
0.5696 | Remote Similarity | NPD312 | Clinical (unspecified phase) |
0.5663 | Remote Similarity | NPD9455 | Approved |
0.5618 | Remote Similarity | NPD2696 | Approved |
0.5618 | Remote Similarity | NPD2695 | Approved |
0.5618 | Remote Similarity | NPD2697 | Approved |
0.5618 | Remote Similarity | NPD2694 | Approved |
0.5607 | Remote Similarity | NPD4838 | Approved |
0.5607 | Remote Similarity | NPD4836 | Approved |
0.5607 | Remote Similarity | NPD4835 | Approved |
0.5607 | Remote Similarity | NPD4837 | Approved |
0.5604 | Remote Similarity | NPD355 | Phase 2 |
PubChem CID   | 15545739 |
ChEMBL   | CHEMBL518563 |
ZINC   |
Molecular Weight:   | 462.38 |
ALogP:   | -4.1327 |
MLogP:   | 3.99 |
XLogP:   | 5.961 |
# Rotatable Bonds:   | 1 |
Polar Surface Area:   | 45.17 |
# H-Bond Aceptor:   | 5 |
# H-Bond Donor:   | 1 |
# Rings:   | 5 |
# Heavy Atoms:   | 33 |